S002 Updates in Cutaneous Oncology
DESCRIPTION
Dermatologists’ knowledge is essential to the improvement of diagnosis and management of pediatric and adult patients with skin cancers. A multi-disciplinary panel with expertise in pediatric and adult oncodermatology, cutaneous lymphomas, Mohs surgery, and surgical oncology will provide a high-yield review of pathophysiology, state-of-the-art diagnostic studies, and discuss therapeutic strategies in cutaneous oncology patients. A patient will participate and present “Living with Gorlin syndrome and the power of advocacy”. This session is targeted to dermatologists, residents, and practitioners involved in the care of cutaneous oncology patients.
LEARNING OBJECTIVES
Outline updates in pathogenesis of non-melanoma skin cancers, Merkel cell carcinoma, melanoma, and cutaneous T-cell lymphomas in adult and pediatric patients
Discuss the latest molecular, histopathological, and imaging studies that aid in the diagnosis of cutaneous oncology patients
Identify novel therapeutic approaches and formulate management strategies for adult and pediatric patients with non-melanoma skin cancers, Merkel cell carcinoma, melanoma and cutaneous T-cell lymphomas
SCHEDULE
9:00 AM
Opening remarks
Lucia Seminario-Vidal, MD, PhD, FAAD
9:05 AM
Cutaneous Squamous Cell Carcinoma Updates
Jayne S. Joo, MD, FAAD
9:35 AM
Basal Cell Carcinoma: Review and Updates
Allison Weinkle, MD, FAAD
10:00 AM
Living with Gorlin syndrome and the power of advocacy
Julie Breneiser, PA-C
10:20 AM
Panel: Questions and Answers
Lucia Seminario-Vidal, MD, PhD, FAAD, Julie Breneiser, PA-C, Jayne S. Joo, MD, FAAD, Allison Weinkle, MD, FAAD
10:30 AM
Updates in CTCL
Ellen J. Kim, MD, FAAD
10:55 AM
Updates in Merkel Cell Carcinoma
David Miller, MD, PhD, FAAD
11:20 AM
Updates on the Latest Advances in Treatment of Melanoma
Vernon Sondak, MD
11:50 AM
Panel: Questions and Answers
Ellen J. Kim, MD, FAAD, David Miller, MD, PhD, FAAD, Vernon Sondak, MD, Kenneth Y. Tsai, MD, PhD, FAAD
DIRECTOR
Lucia Seminario-Vidal, MD, PhD, FAAD
SPEAKERS
Julie Breneiser, PA-C
Jayne S. Joo, MD, FAAD
Ellen J. Kim, MD, FAAD
David Miller, MD, PhD, FAAD
Vernon Sondak, MD
Kenneth Y. Tsai, MD, PhD, FAAD
Allison Weinkle, MD, FAAD
DISCLOSURES
Julie Breneiser, PA-C
No financial relationships exist with ineligible companies.
Jayne S. Joo, MD, FAAD
No financial relationships exist with ineligible companies.
Ellen J. Kim, MD, FAAD
Galderma USA – Consultant(Honoraria), Investigator(Grants/Research Funding); Innate Pharma S.A. – Investigator(Grants/Research Funding); Solgenix LLC – Investigator(Grants/Research Funding);
David Miller, MD, PhD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Avstera Therapeutics Corp – Advisory Board(Stock Options); Bristol Myers Squibb – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Fees); Checkpoint Therapeutics – Advisory Board(Honoraria), Advisory Board(Stock Options); Kartos Therapeutics – Investigator(Grants/Research Funding); Merck – Advisory Board(Honoraria); NeoImmuneTech – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Xilio Therapeutics – Investigator(Grants/Research Funding);
Lucia Seminario-Vidal, MD, PhD, FAAD
Eli Lilly and Company – Employee(Salary), Employee(Stock);
Vernon Sondak, MD
Bristol-Myers Squibb – Consultant(Honoraria), Data Safety Monitoring Board(Honoraria); Genesis Drug Discovery & Development – Consultant(Honoraria); Merck – Advisory Board(Honoraria); Mural Oncology – Consultant (1099 relationship)(Honoraria); Neogene Therapeutics – Other(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); SkylineDx B.V. – Investigator(Grants/Research Funding); Turnstone Biologics – Investigator(Grants/Research Funding);
Kenneth Y. Tsai, MD, PhD, FAAD
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); Ankyra Therapeutics – Independent Contractor(Grants/Research Funding); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);
Allison Weinkle, MD, FAAD
AbbVie – Investigator(No Compensation Received); TEOXANE Laboratories – Investigator(No Compensation Received);